</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
CB Partner Webinar {{webinarspromoemail3::client_name}} {{webinarspromoemail3::client_only_logo}} {{webinarspromoemail3::client_only_logo_self_hosted}} {{webinarspromoemail3::client_only_logo_alt}} {{webinarspromoemail3::client_only_logo_width}} {{webinarspromoemail3::client_only_logo_custom_css}} {{webinarspromoemail3::client_color}} {{webinarspromoemail3::client_color_darker}} The Clinical Application{br}of Genomic{nbs}Diagnostics true 1 Credit Hour {{webinarspromoemail3::on_demand}} June 2, 2022 at 1:00 PM {{webinarspromoemail3::remove_webinar_date_and_time_1}} ET 1{nbs}HR How Identifying Melanoma{br}Mutations Can Change{br}the Course of{nbs}Treatment SAVE YOUR SEAT https://event.on24.com/wcc/r/3755689/8431B109721F63B4C4372A8B2DFB3F65 {{webinarspromoemail3::header_background_image_none}} https://cdn.brief.vet/Clients/Vidium/060222_Webinar_Partner_Vidium_CustomHeader_600x450%401x.png https://cdn.brief.vet/Clients/Vidium/060222_Webinar_Partner_Vidium_CustomHeader_600x450%402x.png {{webinarspromoemail3::header_background_image_1}} {{webinarspromoemail3::header_background_image_2}} {{webinarspromoemail3::header_background_image_3}} {{webinarspromoemail3::header_background_image_4}} {{webinarspromoemail3::header_background_image_5}} {{webinarspromoemail3::header_background_image_6}} {{webinarspromoemail3::supported_by}} /uploads/060222_webinar_partner_vidium_artboard_46_2_x-7c98d487d307541e217a5739c2342035.jpg {{webinarspromoemail3::client_logo_self_hosted}} 88 {{webinarspromoemail3::client_logo_alt}} {{webinarspromoemail3::client_logo_url}} {{webinarspromoemail3::place_logos_below_content}} true /uploads/060222_webinar_partner_vidium_email_speaker_chon_bw_2_x-514d6d287bf3da6d39d791778c2d2d4a.jpg {{webinarspromoemail3::speaker_image_self_hosted_1}} Esther Chon DVM, DACVIM (Oncology) /uploads/060222_webinar_partner_vidium_email_speaker_wang_2_x-198d7197701b47dcaf16ac7469cd48dc.jpg {{webinarspromoemail3::speaker_image_self_hosted_2}} Guannan Wang PhD {{webinarspromoemail3::speaker_image_3}} {{webinarspromoemail3::speaker_image_self_hosted_3}} {{webinarspromoemail3::speaker_name_3}} {{webinarspromoemail3::speaker_title_3}} {{webinarspromoemail3::speaker_image_4}} {{webinarspromoemail3::speaker_image_self_hosted_4}} {{webinarspromoemail3::speaker_name_4}} {{webinarspromoemail3::speaker_title_4}} {{webinarspromoemail3::speaker_image_5}} {{webinarspromoemail3::speaker_image_self_hosted_5}} {{webinarspromoemail3::speaker_name_5}} {{webinarspromoemail3::speaker_title_5}} {{webinarspromoemail3::speaker_image_6}} {{webinarspromoemail3::speaker_image_self_hosted_6}} {{webinarspromoemail3::speaker_name_6}} {{webinarspromoemail3::speaker_title_6}} true {{webinarspromoemail3::place_speakers_below_content}} Thanks to advancements in cancer genomic diagnostics, the future of canine melanoma management is here. Identifying certain mutations in your patients’ melanoma tumors can aid in diagnosis and guide treatment, including identifying cancers that may respond to the targeted therapy{nbs}palbociclib. {{webinarspromoemail3::inside_the_webinar_2}} {{webinarspromoemail3::inside_the_webinar_3}} Become familiar with the mutations commonly identified in canine melanoma and their clinical{nbs}significance Learn the diagnostic and prognostic utility of mutation information in the clinical management of canine{nbs}melanoma Understand the canine{nbh}specific information for palbociclib, including its pharmacokinetic and toxicology{nbs}data {{webinarspromoemail3::what_youll_learn_4}} {{webinarspromoemail3::what_youll_learn_5}} {{webinarspromoemail3::what_youll_learn_6}} Join us to learn how you can{br}start leveraging new technology to{br}manage patients with canine{br}melanoma in your practice{nbs}today. SAVE YOUR SPOT This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
The Clinical Application of Genomic Diagnostics
RACE approved (1 Credit Hour)(1 Credit Hour)
RACE approved (1 Credit Hour)(1 Credit Hour)
The Clinical Application{br}of Genomic{nbs}Diagnostics
How Identifying Melanoma{br}Mutations Can Change{br}the Course of{nbs}Treatment
Jun  2, 2022
01:00 PM ET (1{nbs}HR)
SAVE YOUR SEAT
SAVE YOUR SEAT
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}
 
Speakers
Esther Chon
DVM, DACVIM (Oncology)
Guannan Wang
PhD
Inside the Webinar
Inside the Webinar
Thanks to advancements in cancer genomic diagnostics, the future of canine melanoma management is here. Identifying certain mutations in your patients’ melanoma tumors can aid in diagnosis and guide treatment, including identifying cancers that may respond to the targeted therapy{nbs}palbociclib.
What you'll learn
  • Become familiar with the mutations commonly identified in canine melanoma and their clinical{nbs}significance
  • Learn the diagnostic and prognostic utility of mutation information in the clinical management of canine{nbs}melanoma
  • Understand the canine{nbh}specific information for palbociclib, including its pharmacokinetic and toxicology{nbs}data
Join us to learn how you can{br}start leveraging new technology to{br}manage patients with canine{br}melanoma in your practice{nbs}today.
SAVE YOUR SPOT
Join us to learn how you can{br}start leveraging new technology to{br}manage patients with canine{br}melanoma in your practice{nbs}today.
SAVE YOUR SPOT
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}
 
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
The Clinical Application of Genomic Diagnostics
RACE approved (1 Credit Hour)(1 Credit Hour)
RACE approved (1 Credit Hour)(1 Credit Hour)
The Clinical Application{br}of Genomic{nbs}Diagnostics
How Identifying Melanoma{br}Mutations Can Change{br}the Course of{nbs}Treatment
Jun  2, 2022
01:00 PM ET (1{nbs}HR)
SAVE YOUR SEAT
SAVE YOUR SEAT
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}
 
Speakers
Esther Chon
DVM, DACVIM (Oncology)
Guannan Wang
PhD
Inside the Webinar
Inside the Webinar
Thanks to advancements in cancer genomic diagnostics, the future of canine melanoma management is here. Identifying certain mutations in your patients’ melanoma tumors can aid in diagnosis and guide treatment, including identifying cancers that may respond to the targeted therapy{nbs}palbociclib.
What you'll learn
  • Become familiar with the mutations commonly identified in canine melanoma and their clinical{nbs}significance
  • Learn the diagnostic and prognostic utility of mutation information in the clinical management of canine{nbs}melanoma
  • Understand the canine{nbh}specific information for palbociclib, including its pharmacokinetic and toxicology{nbs}data
Join us to learn how you can{br}start leveraging new technology to{br}manage patients with canine{br}melanoma in your practice{nbs}today.
SAVE YOUR SPOT
Join us to learn how you can{br}start leveraging new technology to{br}manage patients with canine{br}melanoma in your practice{nbs}today.
SAVE YOUR SPOT
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}